Abstract:Uveitis is a term that combines an extensive group of diseases, which are based on inflammation of the choroid of the eyeball. A special place is given to non-infectious uveitis. This group of diseases has an autoimmune origin and the largest proportion of the incidence falls on them. The largest share of morbidity is from this group of uveitis. Despite the successes in modern approaches to the treatment of uveitis, the issue of timely diagnosis and treatment of diseases of the vascular eye membrane does not lose its relevance. The social significance of this pathology is determined by the growing rate of visual acuity decline, the development of complications and early disability. Many studies have revealed a relationship between the untimely late start of treatment and the likelihood of vision loss leading to a deterioration in the quality of life. The therapy of non-infectious uveitis is based on the suppression of the local immune response. Depending on the activity of the inflammatory process, it may include local treatment (instillation of corticosteroids, nonsteroidal anti-inflammatory drugs and mydriatics) and systemic immunosuppression using corticosteroids, alkylating agents (cyclophosphamide, chlorambucil), antimetabolites (azathioprine, methotrexate, mycophenolate mofetil), T-cell inhibitors (cyclosporine and tacrolimus). According to the experience of clinicians, the therapeutic efficacy of steroids even in high doses in treatment of the chronic uveitis provides only partial remission and is associated with the development of serious side effects. Positive results were found when using a combination of steroids with cytostatics, however, with their prolonged use, it is possible to manifest properties such as hepatotoxicity and nephrotoxicity, mutagenicity, carcinogenicity, sterilization, as well as bone marrow suppression, and, as a consequence, the occurrence of severe thrombocytopenic bleeding and granulocytopenic infections. In the case of intermediate, posterior and severe and moderate panuveitis that does not respond to immunosuppressive therapy with methotrexate and cyclosporine A, patients are transferred to therapy with genetically engineered biological drugs (GIBP). The drugs of biological therapy include selective regulators of cytokine levels. The mechanism of their action is based on the selective cytokines’ binding using monoclonal antibodies or soluble cytokine receptors. This article is devoted to evaluating the effectiveness of biological therapy as the drugs of choice.

Update on Diagnosis and Treatment of Uveitic Glaucoma

Surgical Management in A Patient with Complex Uveitic Glaucoma

Overview and update on cytomegalovirus-associated anterior uveitis and glaucoma

Dealing with the complications of uveitis

Update in Genetics and Surgical Management of Primary Congenital Glaucoma

Surgical Outcomes in Uveitic Glaucoma: Long-Term Evaluation of Trabeculectomy, Non-Penetrating Deep Sclerectomy, Ex-PRESS Shunt and Ahmed Glaucoma Valve. A 3-Year Follow-Up Study

Current Concepts of the Uveitis-Glaucoma-Hyphema (UGH) Syndrome

Glaucoma in Viral Keratouveitis: A Retrospective Review at a Tertiary Eye Hospital

Characteristics of ocular hypertension and uveitic glaucoma amongst patients with noninfectious uveitis: a retrospective cohort study

[Modern achievements in the diagnosis and treatment of glaucoma]

Current Approach in the Diagnosis and Management of Posterior Uveitis

Complications in Intermediate Uveitis: Prevalence, Time of Onset, and Effects on Vision in Short-Term and Long-Term Follow-Up

Acute interface fluid syndrome after laser in situ keratomileusis in a case of cytomegalovirus (CMV) endotheliitis and secondary glaucoma

Ocular Complications of Intermediate Uveitis

Cytomegalovirus endotheliitis with recurrent anterior uveitis and secondary glaucoma misdiagnosed as HLA-B27 uveitis

Review of the Effectiveness of Modern Treatment of Non-Infectious Uveitis

Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis

Epiretinal membranes in patients with uveitis: an update on the current state of management

Effect of Modified Trabeculectomy on the Treatment of Glaucoma Secondary in Uveitis

Treatment of Intermediate Uveitis-associated Retinal Vasoproliferative Tumors: A Case Series

Anterior Segment Optical Coherence Tomography in Uveitis-Glaucoma-Hyphema Syndrome